Voluntary Type II Recall for Alysena 28

Apotex had initiated a voluntary Type II recall to the retail and pharmacy level for Alysena™ 28 (lot LF01899A), on behalf of the fabricator, Laboratorios Leon Farma SA, due to the potential for a packaged unit to contain two rows of placebo instead of one row (14 tablets instead of 7 tablets) and two rows of active contraceptive tablets (14 tablets instead of 21 tablets) in the blister pack.

How Well Americans Are Preventing Cancer

Most of us know what we can do to help prevent cancer – don’t smoke, eat a healthy diet, stay physically active and get screened to detect cancer at its earliest stages. The American Cancer Society has released its annual report card on how well we’re doing in all these areas.

Extra Pounds Weigh Heavy on Female Hearts

Obesity is bad for the heart. While some research has found that a little extra fat may help you live longer, a new study finds that even a slight rise in BMI can tip the scales against you.

Smoking is Bad for Bone Health

Osteoporosis is often regarded as a disease of old age. But the path to osteoporosis may start much earlier in life, especially for girls who smoke or show signs of depression.

Googling Seasonal Mental Health

Can the seasons have an effect on mental health? In some people, seasonal affective disorder and depressive symptoms worsen during winter months. But a new study shows that the weather may impact more than a handful of mental health conditions.

Red Alert: Rosacea’s Social Minefield

For 16 million Americans, rosacea brings a redness to the face that can cause self-consciousness. Rosacea Awareness Month this April highlights the social pitfalls of rosacea and treatments for the condition.

UTI Burden with Schizophrenia

Urinary tract infections are a pretty common problem. But for people with schizophrenia, that type of infection may be even more common and may go unnoticed and untreated for a while.

Bird Flu Cases Now Number 28

Counts of bird flu cases in China continue to rise, but news of at least one patient’s recovery is announced.

Looking into Breast Cancer Breakthrough

The FDA has given Pfizer’s breast cancer compound a “Breakthrough Therapy” designation. This will fast-track the medication’s development and review because this compound may offer important new treatments advantages.

Frank A. Vicini, MD, FACR

Dr. Frank A. Vicini is the Chief Academic Officer for Michigan Healthcare Professionals and 21st Century Oncology as well as Professor of Radiation Oncology.

Pages

Subscribe to rxwiki.com RSS